Horizon 2020 Health, Demographic Change and Wellbeing€¦ · involving behavioural, sociological, health) • Common, flexible and open ICT solutions which can be adapted to specific

TÜBİTAK

Horizon 2020 Health, Demographic Change and Wellbeing

TÜBİTAK

H2020 - 3 Priorities

Excellent Science

Industrial Leadership

Societal Challenges

7 focus challenges

Horizon 2020 is a funding programme for all types of actors involved in research and innovation – academia, research, industry and other stakeholder organisations. Horizon 2020 contains a number of different funding programmes and mechanisms, and is based on a structure of three pillars.

TÜBİTAK

Priority 3: Societal Challanges

3

Proposed Funding (billion €) 29,64

Health, demographic change and wellbeing 7,47

Food security, sustainable agriculture and forestry, marine and maritime and in land water research and the Bioeconomy

3,85

Secure, clean and efficient energy 5,91

Smart, green and integrated transport 6,33

Climate action, environment, resource efficiency and raw materials

3,08

Inclusive, innovative and reflective societies 1,31

Secure societies 1,69

TÜBİTAK

Health in EU Framework Programmes

2002-2006 2,2 b Euro

FP6

2007-2013 6,1 b Euro

FP7

2014-2020 7,5 b Euro

H2020

«Health, demographic change and wellbeing» under H2020 Societal Challenges Priority has a budget of 7,4 billion Euro, the highest among societal challenges.

TÜBİTAK

Based on

TÜBİTAK

H2020 Health, Demographic Change and Wellbeing

• The H2020 «Health, demographic change and wellbeing» societal challenge covers FP7 themes of Health under Cooperation priority , ICT e-Health and related CIP topics.

FP7 Health FP7 CIP, ICT e-Health

TÜBİTAK

• Strengthening competitiveness of EU industries – development of new market opportunities.

• Multidisciplinary approach - fostering cooperation between academic and industrial sectors.

• SME Instrument and innovation calls, prizes and research- industry collaborations are in focus.

H2020 Health, Demographic Change and Wellbeing

TÜBİTAK

General Call Info

• Differs from FP7 The work programmes are for 2 years. (2014-2015)

• A focus call covering research and innovation calls is present, that gives a general scope for each theme.

– Objectives:

Create opportunities for real breakthrough research

Translation of findings into the clinic

Reduce health inequalities

Promote active and healthy ageing

• Total budget for 2014&2015:

1,2 billion Euro

TÜBİTAK

SC1 Health, demographic change and wellbeing call 2014 (&2015)

2014 call launch date: 11 December 2013

2 focus calls:

1. Focus Area Call: Personalising health and care (PHC) H2020-PHC-2014

2. Co-ordination Activities Call H2020-HCO-2014

TÜBİTAK

Call topics to be launched in 2014

TÜBİTAK

2014/2015 Call

7 Focus Areas

1. Understanding health, ageing and disease

2. Effective health promotion, disease prevention, preparedness and screening

3. Improving diagnosis

4. Innovative treatments and technologies

5. Advancing active and healthy ageing

6. Integrated, sustainable, citizen-centered care

7. Improving health information, data exploitation and providing an evidence base for health policies and regulation

Focus Area Call: Personalising Health and Care

TÜBİTAK

Understanding health,ageing and disease

2014 topics 2015 topics

1 2


2014 Call

PHC 1-2014 Understanding health, ageing and disease: determinants, risk factors and pathways

TÜBİTAK

• Expected impact: Advance on: Understanding of the combined effects of factors causing disease, contributing to health and healthy aging

• Scope: Proposals should focus on: The identification and validation of trends and determinants of health, and risk factors for disease, through the generation, integration and validation of data derived from different biological/environmental sources


TÜBİTAK

Effective health promotion, disease

prevention, preparedness and screening


4 2


2014 Calls

PHC 5 - 2014 Health promotion and disease prevention: translating ‘omics’ into stratified approaches

PHC 6 - 2014 Evaluating existing screening and prevention programmes

PHC 7 - 2014 Improving the control of infectious epidemics and foodborne outbreaks through rapid identification of pathogens (see also SC2)

PHC 8 - 2014 Vaccine development for poverty-related and neglected infectious diseases: Tuberculosis

TÜBİTAK

• Expected impact: Taking a ‘health in all’ approach, linking environment and health, allowing informed decisions on multi-sector interventions and related policies.

• Evidence for the increased use, or discontinuation of, existing screening and prevention programmes allowing informed decisions by policymakers.

• Scope: Proposals will: Develop and assess a personalised / stratified (from a population) health promotion or disease prevention programme.

• Proposals will assess existing screening and disease prevention strategies and programmes, on the basis of health outcomes, quality-of-life, equity and cost-effectiveness and ethical considerations, at the level of the individual or stratified population groups, across Europe.


TÜBİTAK

Improving diagnosis


2 1 (2014-2015)

2014 Calls

PHC 10 - 2014 Development of new diagnostic tools and technologies: in vitro devices, assays and platforms

PHC 12 - 2014 & 2015

Clinical validation of biomarkers and/or diagnostic medical devices


TÜBİTAK

• Expected impact: New in vitro diagnostic tools and methods providing more accurate, more reliable, cost effective and earlier disease diagnosis, patient stratification and prognosis of disease outcome leading to improved clinical decisions and health outcomes.

• Increased clinical availability and exploitation of biomarkers for the benefit of the patient.

• Scope: Proposals will focus on the development and application of new, innovative in vitro diagnostic tools and technologies (not novel applications of existing ones).

• The clinical validation of existing potential biomarkers (not the identification of new ones) is sought.


TÜBİTAK

Innovative treatments and technologies


3 4

2014 Calls

PHC 13 - 2014 New therapies for chronic non-communicable diseases

PHC 15 - 2014 & 2015

Clinical research on regenerative medicine

PHC 17 - 2014 Comparing the effectiveness of existing healthcare interventions in the elderly


TÜBİTAK

• Expected impact: New therapeutic strategies with the highest potential to generate advances in clinical practice for chronic diseases, including multi- or comorbidity.

• Obtain results of in-patient regenerative medicine research so that new therapies can be taken to the next level of testing.

• Evidence base for more effective and safer interventions, and the use of health technology assessment methodology in this target group.

• Scope: Clinical trials supporting proof of concept in humans to estimate the potential clinical efficacy of the novel therapeutic concepts / optimisation of available therapies.

• Proposals will focus on regenerative medicine techniques which are ready for clinical (in-patient) research.

• Proposals will compare the use of currently available (pharmacological as well as non-pharmacological) healthcare interventions in the elderly population.


TÜBİTAK

Advancing active and healthy ageing


2 2

2014 Calls

PHC 19 - 2014 Advancing active and healthy ageing with ICT: Service robotics within assisted living environments

PHC 20 - 2014 Advancing active and healthy ageing with ICT: ICT solutions for independent living with cognitive impairment


TÜBİTAK

• Expected impact: Reduction of admissions and days spent in care institutions, and prolongation of time spent living in own home when ageing with emerging functional impairments.

• Scope: Focus will be on service robotics in assisted living environments which can help an ageing population to remain active and independent for longer. (multi-disciplinary research involving behavioural, sociological, health)

• Common, flexible and open ICT solutions which can be adapted to specific users' needs, allowing them to live independently for longer while experiencing cognitive impairment. (best-practice and viable business and financing models)


TÜBİTAK

Integrated, sustainable, citizen-centered care


2 6

2014 Calls

PHC 23 - 2014 Developing and comparing new models for safe and efficient, prevention oriented, health and care systems

PHC 26 - 2014 Self-management of health and disease: citizen engagement and mHealth


TÜBİTAK

• Expected impact: On the basis of quantitative and qualitative indicators, evidence on new patient-centred, prevention oriented, safe and efficient models for health care systems and services will be produced.

• Scope: As action oriented research, proposals will develop new models for health systems that make these systems more patient-centred, prevention oriented, efficient, safe and sustainable.


TÜBİTAK

Improving health information, data exploitation and providing an evidence base for health policies and regulation


3 3

2014 Calls

PHC 31 - 2014 Foresight for health policy development and regulation

PHC 32 - 2014 Advancing bioinformatics to meet biomedical and clinical needs

PHC 34 - 2014 eHealth interoperability


TÜBİTAK

• Expected impact: the ability to model and track the impact of various factors (internal and internal to the health systems) on population health will be improved.

• Widespread dissemination of the new bioinformatics tools to maximise the accessibility and utility of biomedical data in research and medicine

• Scope: Proposals should identify key driving forces- (external and internal to the health systems) likely to influence health and wellbeing in Europe and beyond in the future. Research should help understand the inter-relationships between these factors; analyse their economic and social impact and suggest alternative policy options to respond to the challenges they pose.

• Proposals will focus on research, including the development of new mathematical, statistical and computational approaches, to address specific bottlenecks in bioinformatics that hold back better understanding and use of biomedical and clinical research data.


TÜBİTAK

2014 Call Coordination Activities

TÜBİTAK

Call Coordination Activities


6 2

2014 Calls

HCO 5 - 2014 Global Alliance for Chronic Diseases: prevention and treatment of type 2 diabetes

Call Coordination Activities

*

* ERA-NETs

• This call for proposals is focused on type 2 diabetes. The aim of this call is to fund projects that will generate new knowledge on interventions and their implementation for the prevention and treatment of type 2 diabetes in low and middle income countries, and in vulnerable populations in high income countries.

TÜBİTAK

Destek ve Koordinasyon Etkinlikleri

• Mobilisation and Mutual Learning Action Plans (MML for short) are one means of ensuring the engagement of all relevant groups and aim to tackle research and innovation related challenges by creating partnerships with a variety of perspectives, knowledge and experience.

2014 Calls

HCO 15 - 2014 Mobilisation and mutual learning action plan in the area of societal challenge 1

TÜBİTAK

Health, demographic change and wellbeing / 2014-2015 (indicative basis)

•Advancing active and healthy ageing with ICT •Service robotics within assisted living environments •ICT solutions for independent living with cognitive impairments •ICT solutions enabling early risk detection and intervention •Integrated, sustainable, citizen-centred care •ICT-based approaches for integrated care (beyond current state-of-art in tele-health and tele-care) •Self-management of health and disease •Public-procurement of innovative eHealth services •Improving health information and data exploitation •Digital representation of health data to improve diagnosis and treatment •eHealth interoperability

TÜBİTAK

TÜBİTAK

TÜBİTAK

…ETC

EU

Financial

Regulation SINGLE SET OF RULES

for Horizon 2020

Simplification

http://eit.europa.eu/home.html

http://www.eurostars-eureka.eu/home.do

TÜBİTAK

Rules for Participation

• A single set of rules:

• One project – one funding rate

Maximum of 100% of the total eligible costs (except for innovation actions, where a 70% maximum will apply for profit making entities)

• Simple evaluation criteria

• New forms of funding aimed at innovation

• International participation

• Simpler rules for grants

• Fewer, better targeted controls and audits

• Improved rules on intellectual property 33

TÜBİTAK

Conditions for participation

• Standard collaborative actions

• At least 3 legal entitities in 3 member/assocciated countries

• ERC, SME instrument, programme co-fund, coordination and support; only one legal entitity is ok

• Additional conditions: written in the work plan- SME instrument

34

TÜBİTAK

Funding opportunities- proposal submission

• Calls: all call related documents published on the participant portal

• How to find opportunities

• Search a topic: description, conditions, submission

• Find your project partners

• Also check Fit for Health database!

35

TÜBİTAK

Electronic submission

• System accessed from the call page

• ECAS password

• PICS for all partners

• Prepare proposal Online for Part A- structured part

Upload Part B- pdf file

• Submit your proposal

• Validation checks

• Complete submission before 17.00 h deadline

36

TÜBİTAK

Part A

Section 1 • title, acronym, objective • fixed and free keyword • 2000 character abstract • Previous/ current submission • Declarations Section 2 (one form per partner) • PIC compulsory • Department • Dependences (btw partners) • Contact information • Other contact information

37

TÜBİTAK

Part A

Section 3

• Cost and requested grant details

• Budget- direct costs (subcontracters, 3rd parties)

Section 4

• Ethics

Section 5

• Questionnaire

38

TÜBİTAK

Part B - pdf

• Based around evoluation criteria

• Excellence

• Impact

• Implementation

39

TÜBİTAK

Tips and advice

• Consistent message throughout the document

• Apply evidence

• Simplify but do not generalise

• Get central concept diagrams in place first

• Each partner should clearly contribute to the programme

• Ensure all parties gain something from the interaction

• Good sight on risks and contingency plans

40

TÜBİTAK

• Cordis: http://cordis.europa.eu/home_en.html

• Participant portal: http://ec.europa.eu/research/participants/portal/page/home

• Fit for Health: http://www.fitforhealth.eu/

• Health project database: http://www.healthcompetence.eu

• Register as an expert: http://ec.europa.eu/research/participants/portal/page/experts

Further information

http://cordis.europa.eu/home_en.html

http://ec.europa.eu/research/participants/portal/page/home

http://www.fitforhealth.eu/

http://www.healthcompetence.eu/

http://ec.europa.eu/research/participants/portal/page/experts



TÜBİTAK

A.Özge GÖZAY H2020 Health NCP

TÜBİTAK

AB Çerçeve Programlar Ulusal Koordinasyon Ofisi Atatürk Bulvarı 221, Kavaklıdere, Ankara

Telefon: + 90 (312) 468 5300 /1976-1007

E-posta: [email protected]

[email protected]

Documents

Horizon 2020 Health, Demographic Change and Wellbeing€¦ · involving behavioural, sociological, health) • Common, flexible and open ICT solutions which can be adapted to specific